Some studies have demonstrated that elevated levels of resistin lead to metabolic disorders, which are associated with diabetes, non-insulin dependent, acquired systemic lipodystrophy, rheumatoid arthritis, etc. [13–15]. Here, RETN is linked to metabolic disease.